DT Cloud Acquisition Corp Announces Entering Into A Business Combination Agreement With Maius Pharmaceutical
DT Cloud Acquisition Corp Announces Entering Into A Business Combination Agreement With Maius Pharmaceutical
DT Cloud Acquisition Corporation (NASDAQ:DYCQU, DYCQ, DYCQR))))) ("DT Cloud" or the "SPAC"), a publicly-traded special purpose acquisition company, and Maius Pharmaceutical Co., Ltd. ("Maius" or the "Company"), a biopharmaceutical R&D company, announced that they had entered into a definitive business combination agreement (the "Business Combination Agreement") for the merger transactions (the "Business Combination," and the transactions in connection with the Business Combination collectively, the "Transaction"). As contemplated in the Business Combination Agreement, upon closing of the Transaction, Maius will become a wholly-owned subsidiary of Maius Pharmaceutical Group Co., Ltd., a newly formed holding company ("Pubco"), the securities of which will be listed on The Nasdaq Stock Market LLC ("Nasdaq").
Dt Cloud收购公司（纳斯达克：DYCQU、DYCQ、DYCQR）("Dt Cloud"或"SPAC"），是一家公开交易的特殊目的收购公司，Maius药品有限公司（"Maius"或"公司"）是一家生物药品研发公司，宣布它们已签署最终业务合并协议（"业务合并协议"），用于合并交易（"业务合并"，与业务合并相关的交易统称为"交易"）。根据业务合并协议的规定，在交易完成后，Maius将成为新成立的控股公司Maius药品集团有限公司（"Pubco"）的全资子公司，其证券将在纳斯达克股票市场（"纳斯达克"）上市。
